Applications and considerations for the use of genetically engineered mouse models in drug development
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Applications and considerations for the use of genetically engineered mouse models in drug development
Authors
Keywords
Genetically engineered mouse models, GEMM, Drug development, Knock-out mice, Drug safety
Journal
CELL AND TISSUE RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-05
DOI
10.1007/s00441-019-03101-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Humanized mouse models of immunological diseases and precision medicine
- (2019) Leonard D. Shultz et al. MAMMALIAN GENOME
- Genetically engineered pigs as models for human disease
- (2018) Carolin Perleberg et al. Disease Models & Mechanisms
- CYP-humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity
- (2018) Karl-Dimiter Bissig et al. DRUG METABOLISM AND DISPOSITION
- Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β
- (2018) Bernd Bohrmann et al. JOURNAL OF ALZHEIMERS DISEASE
- OTULIN limits cell death and inflammation by deubiquitinating LUBAC
- (2018) Klaus Heger et al. NATURE
- LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis
- (2018) Nieves Peltzer et al. NATURE
- Genome Editing of Pigs for Agriculture and Biomedicine
- (2018) Huaqiang Yang et al. Frontiers in Genetics
- Ubiquitin ligase COP1 coordinates transcriptional programs that control cell type specification in the developing mouse brain
- (2018) Kim Newton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome Toxicity and Impaired Stem Cell Function after Conditional Activation of CreERT2 in the Intestine
- (2018) Natacha Bohin et al. Stem Cell Reports
- Accelerating Biomedical Discoveries through Rigor and Transparency
- (2017) Judith A. Hewitt et al. ILAR JOURNAL
- Application of genome editing technologies in rats for human disease models
- (2017) Kazuto Yoshimi et al. JOURNAL OF HUMAN GENETICS
- Microbiota and reproducibility of rodent models
- (2017) Craig L Franklin et al. LAB ANIMAL
- Krasmutant genetically engineered mouse models of human cancers are genomically heterogeneous
- (2017) Wei-Jen Chung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reproductive and developmental toxicology studies with gantenerumab in PS2APP transgenic mice
- (2017) Paul Barrow et al. REPRODUCTIVE TOXICOLOGY
- Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease
- (2017) Claire E. Le Pichon et al. Science Translational Medicine
- Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice
- (2017) Janet Lau et al. Nature Communications
- Retinoid-related orphan receptor γ (RORγ) adult induced knockout mice develop lymphoblastic lymphoma
- (2016) Maria Liljevald et al. AUTOIMMUNITY REVIEWS
- RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
- (2016) K Newton et al. CELL DEATH AND DIFFERENTIATION
- Innovation in the pharmaceutical industry: New estimates of R&D costs
- (2016) Joseph A. DiMasi et al. JOURNAL OF HEALTH ECONOMICS
- Preclinical Safety Profile of a Depleting Antibody against CRTh2 for Asthma: Well Tolerated Despite Unexpected CRTh2 Expression on Vascular Pericytes in the Central Nervous System and Gastric Mucosa
- (2016) Kathila S. Rajapaksa et al. TOXICOLOGICAL SCIENCES
- Identification of Modifier Genes in a Mouse Model of Gaucher Disease
- (2016) Andrés D. Klein et al. Cell Reports
- Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences
- (2016) Gillian M. Lavelle et al. Biomed Research International
- Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
- (2015) Stephane Pelletier et al. IMMUNITY
- Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
- (2015) Daniel V.T. Catenacci et al. JOURNAL OF CLINICAL ONCOLOGY
- Translational value of mouse models in oncology drug development
- (2015) Stephen E Gould et al. NATURE MEDICINE
- Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations
- (2015) S. Okada et al. SCIENCE
- Inhibition of the kinase ITK in a mouse model of asthma reduces cell death and fails to inhibit the inflammatory response
- (2015) Yonglian Sun et al. Science Signaling
- Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
- (2015) Reina N. Fuji et al. Science Translational Medicine
- Regulatory Forum Opinion Piece*
- (2015) Abigail C. Jacobs et al. TOXICOLOGIC PATHOLOGY
- Inhibition of the kinase ITK in a mouse model of asthma reduces cell death and fails to inhibit the inflammatory response
- (2015) Yonglian Sun et al. Science Signaling
- Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells
- (2014) T. T. Junttila et al. CANCER RESEARCH
- Cutting Edge: RIPK1 Kinase Inactive Mice Are Viable and Protected from TNF-Induced Necroptosis In Vivo
- (2014) Apostolos Polykratis et al. JOURNAL OF IMMUNOLOGY
- RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity
- (2014) Pratyusha Mandal et al. MOLECULAR CELL
- Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
- (2014) David Cook et al. NATURE REVIEWS DRUG DISCOVERY
- Phenotype of Transgenic Mice Carrying a Very Low Copy Number of the Mutant Human G93A Superoxide Dismutase-1 Gene Associated with Amyotrophic Lateral Sclerosis
- (2014) Jeffrey S. Deitch et al. PLoS One
- Genomic responses in mouse models greatly mimic human inflammatory diseases
- (2014) Keizo Takao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition
- (2014) W. J. Kaiser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis
- (2014) K. Newton et al. SCIENCE
- Fialuridine Induces Acute Liver Failure in Chimeric TK-NOG Mice: A Model for Detecting Hepatic Drug Toxicity Prior to Human Testing
- (2014) Dan Xu et al. PLOS MEDICINE
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
- (2013) Haoyi Wang et al. CELL
- Generation of gene-modified mice via Cas9/RNA-mediated gene targeting
- (2013) Bin Shen et al. CELL RESEARCH
- The use of genetically modified mice in cancer risk assessment: Challenges and limitations
- (2013) David A. Eastmond et al. CRITICAL REVIEWS IN TOXICOLOGY
- Genetically engineered mouse models of pancreatic adenocarcinoma
- (2013) Carmen Guerra et al. Molecular Oncology
- Genomic responses in mouse models poorly mimic human inflammatory diseases
- (2013) Junhee Seok et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulatory Forum Commentary
- (2013) Daniel Morton et al. TOXICOLOGIC PATHOLOGY
- Pharmacological inhibition of Polo Like Kinase 2 (PLK2) does not cause chromosomal damage or result in the formation of micronuclei
- (2013) Kent Fitzgerald et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- IAPs limit activation of RIP kinases by TNF receptor 1 during development
- (2012) Maryline Moulin et al. EMBO JOURNAL
- GLP-1 Receptor Agonists and the Thyroid: C-Cell Effects in Mice Are Mediated via the GLP-1 Receptor and not Associated with RET Activation
- (2012) Lars Wichmann Madsen et al. ENDOCRINOLOGY
- Raise standards for preclinical cancer research
- (2012) C. Glenn Begley et al. NATURE
- Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation
- (2012) A. Dey et al. SCIENCE
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Nonclinical safety strategies for stem cell therapies
- (2012) Michaela E. Sharpe et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Zebrafish Models for Human Cancer
- (2012) H. R. Shive VETERINARY PATHOLOGY
- Supporting conditional mouse mutagenesis with a comprehensive cre characterization resource
- (2012) Caleb S. Heffner et al. Nature Communications
- Prostate Epithelial Pten/TP53 Loss Leads to Transformation of Multipotential Progenitors and Epithelial to Mesenchymal Transition
- (2011) Philip Martin et al. AMERICAN JOURNAL OF PATHOLOGY
- A knockout mouse resource for the biomedical research community
- (2011) K. C. Kent Lloyd Annals of the New York Academy of Sciences
- Assessing the Safety of Stem Cell Therapeutics
- (2011) Chris E.P. Goldring et al. Cell Stem Cell
- Mouse models of cystic fibrosis: Phenotypic analysis and research applications
- (2011) Martina Wilke et al. Journal of Cystic Fibrosis
- Robust Central Reduction of Amyloid- in Humans with an Orally Available, Non-Peptidic -Secretase Inhibitor
- (2011) P. C. May et al. JOURNAL OF NEUROSCIENCE
- Believe it or not: how much can we rely on published data on potential drug targets?
- (2011) Florian Prinz et al. NATURE REVIEWS DRUG DISCOVERY
- Transgenic Animal Models in Toxicology: Historical Perspectives and Future Outlook
- (2011) Darrell R. Boverhof et al. TOXICOLOGICAL SCIENCES
- A Critical Review of the Effectiveness of Rodent Pharmaceutical Carcinogenesis Testing in Predicting for Human Risk
- (2011) C. L. Alden et al. VETERINARY PATHOLOGY
- Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in Intestine
- (2010) Ken Cadwell et al. CELL
- Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models
- (2010) Mallika Singh et al. NATURE BIOTECHNOLOGY
- Tamoxifen-Independent Recombination in the RIP-CreER Mouse
- (2010) Yanmei Liu et al. PLoS One
- Carcinogenicity Assessments of Biotechnology-Derived Pharmaceuticals
- (2010) John L. Vahle et al. TOXICOLOGIC PATHOLOGY
- Direct Hematological Toxicity and Illegitimate Chromosomal Recombination Caused by the Systemic Activation of CreERT2
- (2009) A. Y. Higashi et al. JOURNAL OF IMMUNOLOGY
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- An Industry Perspective on the Utility of Short-Term Carcinogenicity Testing in Transgenic Mice in Pharmaceutical Development
- (2009) Richard D. Storer et al. TOXICOLOGIC PATHOLOGY
- Species selection considerations for preclinical toxicology studies for biotherapeutics
- (2008) Jeanine L Bussiere Expert Opinion on Drug Metabolism & Toxicology
- A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells
- (2008) Ken Cadwell et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started